Log in to save to my catalogue

Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensiv...

Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensiv...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f587d1db428c43c381aa7b8b0f3128b6

Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances

About this item

Full title

Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances

Publisher

England: BioMed Central Ltd

Journal title

Journal of nanobiotechnology, 2022-03, Vol.20 (1), p.109-42, Article 109

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Liver cancer is considered one of the deadliest diseases with one of the highest disease burdens worldwide. Among the different types of liver cancer, hepatocellular carcinoma is considered to be the most common type. Multiple conventional approaches are being used in treating hepatocellular carcinoma. Focusing on drug treatment, regular agents in...

Alternative Titles

Full title

Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f587d1db428c43c381aa7b8b0f3128b6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f587d1db428c43c381aa7b8b0f3128b6

Other Identifiers

ISSN

1477-3155

E-ISSN

1477-3155

DOI

10.1186/s12951-022-01309-9

How to access this item